| RD662 - Report on Pharmacist Initiation of Therapeutic Interchange – October 2025
 Executive Summary: Pursuant to SB745 passed during the 2025 General Assembly Session, the Board of Pharmacy convened a workgroup which met on August 12, 2025. The workgroup considered the required topics designated in SB745, which were as follows: 1. Review and analyze the current authority of pharmacists to initiate therapeutic interchange under all health carriers and plans and health care reimbursement methods, including plans covered by the Employee Retirement Income Security Act of 1974; 2. Make recommendations to streamline the existing therapeutic interchange process in the Commonwealth; and 3. Make recommendations for the modernization of such therapeutic interchange authority, particularly in cases of prescription drug shortages. During its review of current laws regarding therapeutic interchange in other states (Appendices 1 and 2), the workgroup appeared to reach consensus on several recommendations for possible legislation to authorize therapeutic interchange. Those recommendations are detailed below in Part IV. Workgroup Members(*1) Erin Barrett, JD Jared Calfee Scott Castro Craig Connors Joshua Crawford, PharmD Jennifer Deschenes, JD, MS Joanne Dial, PharmD Shannon Dowdy, PharmD JoeMichael Fusco, PharmD Johnny Garcia, PharmD Sharon Gatewood, PharmD Bill Hutchens, MD Caroline Juran, RPh Larry Kocot, JD, Chair Randall Mangrum, DNP, RN Laurie Mauthe, PharmD Arne Owens Jamie Smith, PharmD Jason Spouse, PharmD Stephanie Wheawill, PharmD Derek Webb, PharmD Ling Yuan, PharmD | 
 
                                